Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1995
03/22/1995CN1100408A Pentanoic acid derivatives
03/22/1995CN1100272A Composition and process for enhancing the pre-adult growth and feed conversion efficiency of a porcine animal
03/22/1995CA2132479A1 Pharmaceutical composition for treating or preventing allergic rhinitis
03/21/1995US5399748 Derivatives of aspartic acid and glutamic acid having anticholecystokinin activity
03/21/1995US5399743 Osteoporosis, hypercalcemia
03/21/1995US5399698 Quinolin-2-yl-methoxybenzylhydroxyureas
03/21/1995US5399696 Excitatory amino acid receptor antagonists; nervous system disorders
03/21/1995US5399587 Biologically active compounds
03/21/1995US5399586 Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity
03/21/1995US5399574 5-hydroxytryptamine agonists; vasoconstrictors
03/21/1995US5399570 Aspartic acid derivatives, and their use for inhibiting platelete aggregation
03/21/1995US5399550 Physiologically active substance derived or malt and process for the production thereof
03/21/1995CA1334826C Pharmaceutical compositions comprising benzylidene-and cinnamylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novelcompounds and their preparation
03/16/1995WO1995007364A1 Nucleic acid ligands and improved methods for producing the same
03/16/1995WO1995007294A1 Pseudo- and non-peptide bradykinin receptor antagonists
03/16/1995WO1995007291A1 Kininogen inhibitors
03/16/1995WO1995007279A2 Process for the preparation of indolizine derivatives
03/16/1995WO1995007274A1 Bicyclic aromatic compounds as therapeutic agents
03/16/1995WO1995007262A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
03/16/1995WO1995007257A1 Difluoro statone antiviral analogs
03/16/1995WO1995007103A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
03/16/1995WO1995007098A1 Methods for regulating gastrointestinal motility
03/16/1995WO1995007079A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
03/16/1995WO1995007075A1 Novel aromatic amine derivatives
03/16/1995WO1995003405A3 Enzymatic method for modification of recombinant polypeptides
03/16/1995WO1995002420A3 Prodrugs of protein tyrosine kinase inhibitors
03/16/1995WO1995000643A3 Human cell adhesion protein aamp-1 and uses thereof
03/16/1995CA2171308A1 Process for the preparation of indolizine derivatives
03/16/1995CA2170896A1 Kininogen inhibitors
03/16/1995CA2170488A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
03/16/1995CA2170056A1 1,4-benzodioxane derivatives for treating cns disorders
03/16/1995CA2169536A1 Nucleic acid ligands and improved methods for producing the same
03/16/1995CA2168738A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
03/15/1995EP0643075A1 Novel peptide having elastase inhibitor activity and process for producing the same
03/15/1995EP0643071A1 Compound for inhibiting bone resorption and accelerating osteogenesis
03/15/1995EP0643069A1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof
03/15/1995EP0643068A1 Erythromycin derivative
03/15/1995EP0643060A2 Sulfonylbenzyl-substituted benzimidazoles, process for their preparation, and their pharmaceutical use
03/15/1995EP0642799A1 Improved prodrugs for enzyme mediated activation
03/15/1995EP0642591A1 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
03/15/1995EP0642580A1 Hepatocyte growth factor variants
03/15/1995EP0642521A1 Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
03/15/1995EP0642520A1 Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
03/15/1995EP0642519A1 Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism
03/15/1995EP0642518A1 Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism
03/15/1995EP0642517A1 Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism
03/15/1995EP0642513A1 Indolocarbazole imides and their use
03/15/1995EP0642509A1 Novel potent inducers of terminal differentiation and methods of use thereof
03/15/1995EP0642508A1 Tricyclic quinoxalinediones as glutamate receptor antagonists
03/15/1995EP0642351A1 New pharmaceutical uses of krill enzymes
03/15/1995EP0573604B1 Methods for the treatment of osteoporosis
03/15/1995EP0563153B1 N-(mercaptoalkyl)amides
03/15/1995EP0526478B1 3-indolyl thioacetate derivatives
03/15/1995EP0510028B1 Thioformamide derivatives
03/15/1995EP0414741B1 Further improvements relating to drug delivery systems
03/15/1995EP0394333B1 Uses of sulphated sugars
03/15/1995CN1027891C 5-substituted ornithine derivatives.
03/14/1995US5397799 Anxiolytic agents, antidepressants
03/14/1995US5397797 Treatment of ocular hypertension with an ocular synergistic combination
03/14/1995US5397796 Inhibitors of platelet aggregation, metastasis of carcinoma cells and osteoclast binding to the bone surfaces
03/14/1995US5397781 Pyrimidine derivatives
03/14/1995US5397778 Enteral formulations for treatment of inflammation and infection
03/14/1995US5397775 26,27-dimethylene-1α,25-dihydroxyvitamin D2 and 26,27-dimethylene-24-epi-1α,25-dihydroxyvitamin D2 and methods for preparing same
03/14/1995US5397703 Method for generation of antibodies to cell surface molecules
03/14/1995CA1334754C 5-aryl-substituted-2,3-dihydro-imidazo¬1,2-a|furo and -thieno pyridines
03/14/1995CA1334753C Glycerin derivative and its pharmacological use
03/09/1995WO1995006662A1 Neuron regulatory factor for promoting neuron survival
03/09/1995WO1995006647A1 ALKOXY-SUBSTITUTED β-CARBOLINES ACTING ON THE AMPA-RECEPTOR
03/09/1995WO1995006645A1 Benzofuran derivatives as tachykinin antagonists
03/09/1995WO1995006638A1 Tryptamine analogs with 5-ht1d selectivity
03/09/1995WO1995006637A1 Indole and indoline derivatives as 5ht1d receptor antagonists
03/09/1995WO1995006636A1 5-arylindole derivatives
03/09/1995WO1995006486A1 Treatment of human tumors by genetic transformation of human tumor cells
03/09/1995WO1995006410A1 Treatment of chronic inflammatory diseases by angiotension ii receptor antagonists
03/09/1995WO1995001348A3 Imides as inhibitors of tnp alpha
03/09/1995CA2170751A1 Neuron regulatory factor for promoting neuron survival
03/09/1995CA2170615A1 Alkoxy-substituted .beta.-carbolines acting on the ampa-receptor
03/09/1995CA2169557A1 Treatment of human tumors by genetic transformation of human tumor cells
03/09/1995CA2147991A1 Tryptamine analogs with 5-ht1d selectivity
03/08/1995EP0641787A1 2H-naphth[2,3-b]-1,4-oxazine derivatives, their preparation and their use as serotonin 1D (5-HT10) receptor agonists
03/08/1995EP0641779A1 Novel 1-amidinopiperdines and 4-amidinomorpholines as aggregation inhibitions
03/08/1995EP0641355A1 Steroid sulphatase inhibitors
03/08/1995EP0641343A1 4-mercaptoacetylamino- 2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
03/08/1995EP0641329A1 Compounds having angiotensine ii antagonistic activity
03/08/1995EP0641327A1 Novel alpha-mannosidase inhibitors
03/08/1995EP0641320A1 New centrally acting substituted phenylazacycloalkanes
03/08/1995EP0641302A1 Alcohols as potassium channel openers and in treatment of urinary incontinence
03/08/1995EP0641218A1 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality
03/08/1995EP0641201A1 Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids
03/08/1995EP0641193A1 Chemotherapeutic drug combinations
03/08/1995EP0559743B1 Novel hydroxamic acid and n-hydroxyurea derivatives and their use
03/08/1995CN1099801A Peptides
03/08/1995CN1099759A 哌嗪衍生物 Piperazine derivatives
03/08/1995CN1099755A Cyclic derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
03/08/1995CN1099623A Refined male silk moth powder and producing method
03/08/1995CN1099613A Method and medical agent for diagnosis and/or therapy of arthritis
03/08/1995CN1099612A Destroying or inhibiting growth of unwanted cells or tissues
03/08/1995CA2130864A1 Carboxamides
03/07/1995US5395941 Optically active 1,4-hydropyridine compounds
03/07/1995US5395932 2,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
1 ... 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 ... 1564